Regeneron Pharmaceuticals
REGN
$900.16
Share price
0.37%
Change (1 day)
12.94%
Change (1 year)
Categories
Operating Margin for Regeneron Pharmaceuticals (REGN)
Operating Margin as of April 2024 (TTM): 37.68%
According to Regeneron Pharmaceuticals's latest financial reports and stock price the company's current Operating Margin is 37.68%. At the end of 2022 the company had an Operating Margin of 39.91%.
Operating Margin history for Regeneron Pharmaceuticals from 2001 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | 39.91% | -31.21% |
| 2021 | 58.03% | 29.4% |
| 2020 | 44.84% | 45.17% |
| 2019 | 30.89% | -18.82% |
| 2018 | 38.05% | 7.5% |
| 2017 | 35.40% | 29.37% |
| 2016 | 27.36% | -8.35% |
| 2015 | 29.85% | 8.51% |
| 2014 | 27.51% | -18.82% |
| 2013 | 33.89% | 12.74% |
| 2012 | 30.06% | -160.13% |
| 2011 | -50.00% | 119.7% |
| 2010 | -22.76% | 19.95% |
| 2009 | -18.97% | -43.7% |
| 2008 | -33.70% | -63.19% |
| 2007 | -91.55% | -46.05% |
| 2006 | -169.68% | -190.27% |
| 2005 | 187.97% | 5693.39% |
| 2004 | 3.24% | -101.87% |
| 2003 | -173.90% | -68.65% |
| 2002 | -554.63% | 42.23% |
| 2001 | -389.95% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 22.88% | -39.28% | 🇺🇸 USA |
 Novartis NVS | 17.27% | -54.17% | 🇨🇭 Switzerland |
 Amgen AMGN | 34.59% | -8.20% | 🇺🇸 USA |
 Sanofi SNY | 18.21% | -51.67% | 🇫🇷 France |
 Biogen BIIB | 31.30% | -16.93% | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | -108.63% | -388.30% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.